Viridian Therapeutics (VRDN)
22.82
-0.19 (0.83%)
Upcoming Events
Latest Headlines
Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
October 20, 2026 4:00 PM - BizWire
Viridian Intersects Sulphides Throughout 3 km of Step-Out Drilling at Kraken Main
October 2, 2026 1:28 PM - Globe NewsWire
Viridian Therapeutic (VRDN) PT Raised to $38 at RBC Capital
September 22, 2026 7:25 AM - StreetInsider
Viridian Announces Initial Exploration Target at Kraken Main Zone
September 15, 2026 11:09 AM - Globe NewsWire
Viridian Intersects Over 50 Metres of Mineralization from Surface at Kraken Main
September 8, 2026 8:31 AM - Globe NewsWire
Form 4 Viridian Therapeutics, For: Aug 19 Filed by: Tousignant Jennifer
August 20, 2026 8:05 PM - SEC Filing
Form SCHEDULE 13G Viridian Therapeutics, Filed by: Point72 Asset Management, L.P.
August 20, 2026 4:15 PM - SEC Filing
Form 144 Viridian Therapeutics, Filed by: Tousignant Jennifer
August 19, 2026 2:31 PM - SEC Filing
Form 4 Viridian Therapeutics, For: Aug 14 Filed by: Tripuraneni Radhika
August 18, 2026 5:34 PM - SEC Filing
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Paradigm Biocapital Advisors LP
August 14, 2026 4:32 PM - SEC Filing
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Kynam Capital Management, LP
August 14, 2026 12:18 PM - SEC Filing
Form SCHEDULE 13G Viridian Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
August 14, 2026 10:40 AM - SEC Filing
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Deep Track Capital, LP
August 14, 2026 8:33 AM - SEC Filing
Form SCHEDULE 13G Viridian Therapeutics, Filed by: STATE STREET CORP
August 7, 2026 11:13 AM - SEC Filing
Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending
August 6, 2026 3:02 PM - Globe NewsWire
Viridian Therapeutic (VRDN) PT Lowered to $41 at Wedbush
August 6, 2026 9:27 AM - StreetInsider
Viridian Therapeutics, Inc. (VRDN) Misses Q2 EPS by 2c
August 6, 2026 7:41 AM - StreetInsider
Form 10-Q Viridian Therapeutics, For: Jun 30
August 6, 2026 7:32 AM - SEC Filing
Viridian Therapeutics (VRDN) Added to Needham Conviction List
August 6, 2026 7:28 AM - StreetInsider
Form 8-K Viridian Therapeutics, For: Aug 06
August 6, 2026 7:05 AM - SEC Filing
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
August 6, 2026 7:01 AM - BizWire
Full Article List
